# Mifepristone Plus Misoprostol Versus Misoprostol Alone for 2nd Trimester Abortion (14 - 21 Weeks Last Menstrual Period (LMP))

> **NCT00969982** · NA · COMPLETED · sponsor: **Gynuity Health Projects** · enrollment: 238 (actual)

## Conditions studied

- Abortion, Induced

## Interventions

- **DRUG:** mifepristone+misoprostol
- **DRUG:** misoprostol+placebo

## Key facts

- **NCT ID:** NCT00969982
- **Lead sponsor:** Gynuity Health Projects
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 238 (ACTUAL)
- **Last updated:** 2014-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00969982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00969982, "Mifepristone Plus Misoprostol Versus Misoprostol Alone for 2nd Trimester Abortion (14 - 21 Weeks Last Menstrual Period (LMP))". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00969982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*